Related Experiment Video
Updated: Jun 11, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations
Adrian Covic1, Luminita Voroneanu, David Goldsmith
1Nephrology Clinic, Parhon University Hospital, Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania. lumivoro@yahoo.com
Insights
Vitamin D deficiency is common in chronic kidney disease (CKD) patients. This review explores how vitamin D impacts cardiovascular health and left ventricular hypertrophy (LVH) in CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in chronic kidney disease (CKD) patients.
- Vitamin D deficiency is prevalent in CKD, coinciding with frequent left ventricular abnormalities.
- Left ventricular hypertrophy (LVH) progresses with declining renal function and dialysis initiation.
Purpose of the Study:
- To review the evidence linking vitamin D to cardiac structure and function in CKD patients.
- To investigate the potential mechanisms connecting mineral metabolism and LVH.
- To examine the dual role of vitamin D in cardiovascular outcomes and LVH.
Main Methods:
- Review of recent observational studies and existing literature.
- Analysis of factors contributing to LVH in CKD patients.
- Exploration of vitamin D's association with cardiovascular mortality and LVH.
Main Results:
- Observational studies suggest vitamin D treatment may reduce cardiovascular death and LVH in dialysis patients.
- Conversely, excess vitamin D is linked to hypercalcemia, vascular calcification, and reduced survival.
- The relationship between vitamin D, mineral metabolism, and cardiac morphology requires further elucidation.
Conclusions:
- Vitamin D's role in CKD cardiovascular health is complex and warrants further investigation.
- Understanding this link is crucial for managing cardiovascular risk in CKD patients.
- Further research is needed to clarify optimal vitamin D management strategies for CKD patients.
Abstract:
Cardiovascular disease is a major cause of death among patients with chronic kidney disease and vitamin D deficiency is a common problem also among these patients. Abnormalities in left ventricular size and function are frequent, as they are encountered in 70-80% of incident dialysis patients. These alterations develop early in the course of renal disease and their prevalence progresses in parallel with the decline in renal function. This process of left ventricular dilatation with compensatory hypertrophy continues after the institution of dialysis therapy, especially in the first year. The main factors responsible for the progression of left ventricular hypertrophy (LVH) are considered to be blood pressure and anemia, and in patients receiving hemodialysis, the arteriovenous fistula, volume overload and abnormalities in mineral metabolism. This additional potential set of factors related to LVH - mineral and bone metabolism - is intriguing and begs an immediate question: by what possible mechanism can these factors be linked to cardiac morphology? Recent observational studies have indeed indicated that vitamin D treatment was associated with a significant reduction of cardiovascular death among dialysis patients, and a reduction in LVH; in contrast, other studies suggested that excess vitamin D contributes to risk of hypercalcemia and vascular calcification, which is associated with reduced survival and morbidity. This review examines the evidence linking vitamin D with cardiac structure and function.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure Drugs: Diuretics
Cardiomyopathy V: Interprofessional Care
